BCDA
Income statement / Annual
Last year (2025), BioCardia Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2025, BioCardia Inc.'s net income was -$8.23 M.
See BioCardia Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$58.00 K |
$477.00 K |
$1.35 M |
$1.02 M |
$145.00 K |
$710.00 K |
$625.00 K |
$479.00 K |
$576.00 K |
| Cost of Revenue |
$505.00 K
|
$4.39 M
|
$7.73 M
|
$8.83 M
|
$640.00 K
|
$4.00 K
|
$358.00 K
|
$517.00 K
|
$690.00 K
|
$746.00 K
|
| Gross Profit |
-$505.00 K
|
-$4.33 M
|
-$7.25 M
|
-$7.48 M
|
$375.00 K
|
$141.00 K
|
$352.00 K
|
$108.00 K
|
-$211.00 K
|
-$170.00 K
|
| Gross Profit Ratio |
0
|
-74.64
|
-15.2
|
-5.53
|
0.37
|
0.97
|
0.5
|
0.17
|
-0.44
|
-0.3
|
| Research and Development Expenses |
$4.96 M
|
$4.39 M
|
$7.73 M
|
$8.83 M
|
$8.56 M
|
$9.81 M
|
$8.56 M
|
$8.45 M
|
$5.80 M
|
$3.33 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.73 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.66 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.32 M
|
$0.00
|
$0.00
|
$0.00
|
$5.09 M
|
$5.86 M
|
$6.00 M
|
$5.76 M
|
$6.40 M
|
$4.11 M
|
| Other Expenses |
-$505.00 K
|
-$715.00 K
|
-$3.33 M
|
-$4.42 M
|
-$640.00 K
|
$0.00
|
$0.00
|
-$3.00 K
|
$2.00 K
|
-$2.00 K
|
| Operating Expenses |
$7.77 M
|
$3.67 M
|
$4.40 M
|
$4.42 M
|
$13.01 M
|
$15.67 M
|
$14.57 M
|
$14.21 M
|
$12.19 M
|
$7.44 M
|
| Cost And Expenses |
$8.28 M
|
$8.06 M
|
$12.12 M
|
$13.25 M
|
$13.65 M
|
$15.67 M
|
$14.92 M
|
$14.73 M
|
$12.88 M
|
$8.18 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$9.00 K
|
$21.00 K
|
$87.00 K
|
$118.00 K
|
$95.00 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$6.00 K
|
$0.00
|
$3.00 K
|
$112.00 K
|
$0.00
|
$0.00
|
$1.74 M
|
| Depreciation & Amortization |
$505.00 K
|
$67.00 K
|
$84.00 K
|
$82.00 K
|
$60.00 K
|
$566.00 K
|
$551.00 K
|
$88.00 K
|
$78.00 K
|
$39.00 K
|
| EBITDA |
-$7.77 M |
-$7.93 M |
-$11.56 M |
-$11.82 M |
-$12.57 M |
-$14.44 M |
-$14.05 M |
-$13.90 M |
-$12.23 M |
-$8.54 M |
| EBITDA Ratio |
0
|
-136.79
|
-24.23
|
-8.74
|
-12.38
|
-99.55
|
-19.78
|
-22.24
|
-25.53
|
-14.82
|
| Operating Income Ratio |
0
|
-137.95
|
-24.41
|
-8.8
|
-12.44
|
-107.1
|
-20.02
|
-22.56
|
-25.9
|
-13.21
|
| Total Other Income/Expenses Net |
$50.00 K
|
$55.00 K
|
$73.00 K
|
-$6.00 K
|
$7.00 K
|
$525.00 K
|
-$496.00 K
|
$115.00 K
|
$97.00 K
|
-$2.70 M
|
| Income Before Tax |
-$8.23 M
|
-$7.95 M
|
-$11.57 M
|
-$11.91 M
|
-$12.62 M
|
-$15.00 M
|
-$14.71 M
|
-$13.99 M
|
-$12.31 M
|
-$10.31 M
|
| Income Before Tax Ratio |
0
|
-137
|
-24.26
|
-8.81
|
-12.44
|
-103.48
|
-20.72
|
-22.38
|
-25.7
|
-17.9
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$115.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$8.23 M
|
-$7.95 M
|
-$11.57 M
|
-$11.91 M
|
-$12.62 M
|
-$15.00 M
|
-$14.71 M
|
-$13.99 M
|
-$12.31 M
|
-$10.31 M
|
| Net Income Ratio |
0
|
-137
|
-24.26
|
-8.81
|
-12.43
|
-103.48
|
-20.72
|
-22.38
|
-25.7
|
-17.9
|
| EPS |
-1.23 |
-2.9 |
-8.19 |
-10.05 |
-11.19 |
-22.2 |
-39.15 |
-48.8 |
-43.5 |
-166.33 |
| EPS Diluted |
-1.23 |
-2.9 |
-8.19 |
-10.05 |
-11.19 |
-22.2 |
-39.15 |
-48.8 |
-43.5 |
-166.33 |
| Weighted Average Shares Out |
$6.67 M
|
$2.74 M
|
$1.41 M
|
$1.18 M
|
$1.13 M
|
$674.58 K
|
$376.29 K
|
$284.28 K
|
$282.67 K
|
$61.99 K
|
| Weighted Average Shares Out Diluted |
$6.67 M
|
$2.74 M
|
$1.41 M
|
$1.18 M
|
$1.13 M
|
$674.58 K
|
$376.29 K
|
$284.28 K
|
$282.67 K
|
$61.99 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
